checkAd
    Crinetics Pharmaceuticals Aktie
    48,00
     
    USD
    -2,87 %
    -1,42 USD
    Letzter Kurs 11.05.24 Nasdaq
    47,98
     
    USD
    4.000 STK
    Geldkurs 10.05.24
    48,00
     
    USD
    100 STK
    Briefkurs 10.05.24
    ISIN: US22663K1079 · WKN: A2JQTJ · SYM: CRNX · USA

    Neueste Nachrichten

    Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    10.05.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
    09.05.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
    08.05.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
    02.05.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    11.04.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients
    19.03.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome
    12.03.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals Announces March 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    11.03.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    28.02.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
    28.02.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
    14.02.24 · globenewswire · Crinetics Pharmaceuticals
    Crinetics Pharmaceuticals Announces February 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    12.02.24 · globenewswire · Crinetics Pharmaceuticals